Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1992
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
other company data
Title:
Unnamed
Year:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: EEC B7 Repeated dose (4 weeks) toxicity study in rats by oral route followed by a 4 week recovery period.
GLP compliance:
yes
Limit test:
no

Test material

1
Chemical structure
Reference substance name:
(S)-5-[2-(acetyloxy)propanamido]-2,4,6-triiodo-1,3-di(chloroformyl)benzene
EC Number:
410-940-7
EC Name:
(S)-5-[2-(acetyloxy)propanamido]-2,4,6-triiodo-1,3-di(chloroformyl)benzene
Cas Number:
60166-91-8
Molecular formula:
C13H8Cl2I3NO5
IUPAC Name:
1-{[3,5-bis(carbonochloridoyl)-2,4,6-triiodophenyl]carbamoyl}ethyl acetate
Test material form:
solid: particulate/powder

Test animals

Species:
rat
Strain:
Sprague-Dawley

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
other: 0.5% Methylcellulose (400 cps) in water.
Details on oral exposure:
Method of administration:
gavage
Duration of treatment / exposure:
Test duration: 28 days
Frequency of treatment:
Dosing regime: 7 days/week
No. of animals per sex per dose:
Male: 5 animals at 50 mg/kg bw/day
Male: 5 animals at 250 mg/kg bw/day
Male: 10 animals at 1000 mg/kg bw/day
Female: 5 animals at 50 mg/kg bw/day
Female: 5 animals at 250 mg/kg bw/day
Female: 10 animals at 1000 mg/kg bw/day

Results and discussion

Results of examinations

Details on results:
Clinical observations:
Lactoftaluro did not induce the appearance either of
clinical signs or body weight modifications.

Food intake was similar in control and treated groups during
both experimental and recovery phases.

Ophtalmoscopic examinations did not show test substance
related modifications.

Laboratory findings:
Hematology, blood chemistry and urinalysis at the end of
both experimental (all groups) and recovery periods (control
group and 3 only) did not show test substance-related
modifications.

Effects in organs:
a) Organ weights at the end of experimental and recovery
periods were similar in control and treated animals.

b) No gross modifications were observed at the autoptic
examinations.

c) No microscopic modifications were observed at the
histological examinations.

Effect levels

open allclose all
Dose descriptor:
NOAEL
Effect level:
1 000 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: original NCD unit is mg/kg/day.
Dose descriptor:
NOEL
Effect level:
1 000 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: original NCD unit is mg/kg/day.

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
Classified as: Not classified